As thousands nationwide wait for a life-giving organ, Houston researchers and physicians at Baylor College of Medicine and CHI St. Luke’s Health have teamed up with InformAI to investigate the potential use of Artificial Intelligence (AI) technologies to enhance liver transplant outcomes.
Abbas Rana, M.D., assistant professor of surgery in Baylor’s department of surgery, division of abdominal transplantation, performs numerous kidney and liver transplantation surgeries each year. Artificial intelligence or AI offers hope because he has been underwhelmed with the tools doctors currently have to determine whether a donated organ will be a good match for a patient.
“Our field is highly regulated and we are dependent on regression models,” Rana said. “This is a way of taking our models and using a more sophisticated form of model generation using artificial intelligence and machine learning.”
There are currently more than 113,000 people in need of a lifesaving organ in the United States, according to UNOS, the United Network for Organ Sharing. The private, nonprofit organization manages the nation’s organ transplant system under contract with the federal government. The number of donors and transplants in the U.S. are “at an all-time high,” UNOS reports.
After kidneys, livers are the most-implanted organs.
To make liver transplants more efficient and successful, Rana went to Stuart Corr, Ph.D., assistant professor and director of Baylor’s Interdisciplinary Surgical Technology and Innovation Center (INSTINCT), to begin looking at ways to better match patients with donors.
InformAI CEO Jim Havelka was tapped to build and test a predictor tool powered by AI. Havelka and his team are using liver transplant outcomes from the past 30 years to better inform the device on making the best matches.
“If you look at a lot of existing models today, the correlations tend to be linear in nature,” Havelka said. “These tools are able to extract some very minute details and patterns in the data that are typically missed with more traditional, statistical analysis tools, so the quality of the prediction and correlations are much more refined.”
Ideally, Havelka explains, when the device is developed, it will act as a surgeon’s assistant in matching a donor and a patient.
“We envision using AI to help the clinician decide,” Rana said. “Usually, it is a team—the surgeon with the medical doctor and the hepatologist working in conjunction when they get a certain organ offering for a certain organ recipient. The organ may be marginal—what are the chances they will get a better organ? What are the chances they will die waiting? What are the chances they will survive after you give them this particular organ?”
For the new device, Havelka explains he will be able to streamline 30 years of not only data on transplant patients, but also crunch information on patients who did not receive a transplant, data on the quality of the organs that have been donated and donor health in general.
InformAI is in the process of running the first iterations of the programming with a base model and the group hopes to do a preliminary evaluation in a clinical setting soon.
“We are poised with the opportunity to utilize not only the 300 or more variables within UNOS, but ultimately, to incorporate even greater numbers of variables that are available in electronic databases which we use for patient care now,” said liver transplant specialist John Moore Vierling, M.D. He is professor of medicine and surgery in Baylor’s division of abdominal transplantation, chief of hepatology and director of Baylor Liver Health. “When you look at the totality of information, AI has the capacity—without using a hypothesis-based approach—to find the interactions where there are associations of statistical nature to ultimately understand what data are important without predefining a limit as to what you can analyze.”
Myth: #Pain is just physical.Learn the truth from our @uzo_md and read his advice for getting the right treatment: https://t.co/wIXQFSImcE #endcancer
Tens of thousands of volunteers laid wreaths at VA national cemeteries across the U.S. as part of National Wreaths Across America Day Dec. 14. https://t.co/ENkDR3bqxB
“We need to better understand why #probiotics don’t help and may even be harmful,” says our @carrie_d_mac of the microbiome’s link to the effectiveness of #immunotherapy. #endcancer https://t.co/t6fulbhDcH
Learn how Dr. Zachary Pallister stays fit in this week's Healthy Habits. https://t.co/GLO29z2W2u #healthy #habits
VA mom helping women Veterans… inspired by her Navy daughter https://t.co/immmo4yLt9 via #VAntagePoint
“When I first made eye contact with @MAOnstad, I knew I was where I was supposed to be,” says #uterinecancer survivor Tralisa Woods: https://t.co/iCEfVL0tGj #gyncsm #endcancer
VA’s Office of Mental Health and Suicide Prevention supports proposed three-digit dialing code for suicide hotline https://t.co/a6hiRA6I7Q via #VAntagePoint
@skologinczak We'd like to hear more about your experience. Please send your contact information and Memorial Hermann location to firstname.lastname@example.org so we can look into this.
Wondering what you should be eat to fuel your workout? Registered dietitian, Roberta Anding, breaks it down. https://t.co/BRhtzvO48R #exercise #workouts
@Nanomed_hmri Appreciate the share.
@RobertaS_CIO @InnoMapHou @nataliejharms Appreciate the shout-out.
@lifecourseUofT Thanks for the shout-out.
Dr. Atif Iqbal with @BCM_Surgery discusses the human papillomavirus virus and the rise of anal cancer. https://t.co/GhsLd2flaJ #HPV
University of Houston@UHouston
RT @UHCougars: .@UHouston students, don't forget to claim your ticket!Don't miss out on a 👔𝘽𝙇𝙐𝙀 𝙎𝙃𝙄𝙍𝙏 𝙍𝙀𝘿 𝙏𝙄𝙀 𝙏-𝙎𝙃𝙄𝙍𝙏!! 🤯🎟️| https://…